Halozyme Therapeutics (HALO) Cash from Financing Activities (2010 - 2026)
Halozyme Therapeutics (HALO) posted Cash from Financing Activities of -$326.25 million for Q2 2026, compared with -$298.97 million a year earlier.
Powered by 
Analysis
Halozyme Therapeutics (HALO) Cash from Financing Activities (2010 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Cash from Financing Activities at Halozyme Therapeutics was -$110.75 million; for FY2025, it was -$85.17 million.
- In prior years, Halozyme Therapeutics' Cash from Financing Activities was -$218.86 million in FY2024, -$407.99 million in FY2023, $362.37 million in FY2022 (+365.4%) and $77.87 million in FY2021.
- The Q2 2026 figure stands as the lowest quarterly Cash from Financing Activities in data going back to Q3 2010.
- According to Business Quant data, Cash from Financing Activities for the three prior quarters was -$1.61 million (Q1 2026), $239.52 million (Q4 2025) and -$22.4 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 8.43 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | -8.78 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | -5.05 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 1.76 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | -2.02 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | -47.00 Mn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | -1.48 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 2.34 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | -3.66 Bn |
| 10 | Halozyme Therapeutics | 12.20 Bn | 10.80 Bn | 401.83 Mn | -326.25 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -326.25 Mn |
| Mar 31, 2026 | -1.61 Mn |
| Dec 31, 2025 | 239.52 Mn |
| Sep 30, 2025 | -22.40 Mn |
| Jun 30, 2025 | -298.97 Mn |
| Mar 31, 2025 | -3.32 Mn |
| Dec 31, 2024 | -246.42 Mn |
| Sep 30, 2024 | 18.56 Mn |
| Jun 30, 2024 | 9.48 Mn |
| Mar 31, 2024 | -489,000.00 |
| Dec 31, 2023 | -249.92 Mn |
| Sep 30, 2023 | 4.10 Mn |
| Jun 30, 2023 | 2.45 Mn |
| Mar 31, 2023 | -164.61 Mn |
| Dec 31, 2022 | 6.33 Mn |
| Sep 30, 2022 | -12.40 Mn |
| Jun 30, 2022 | 367.82 Mn |
| Mar 31, 2022 | 624,000.00 |
| Dec 31, 2021 | -156.01 Mn |
| Sep 30, 2021 | -60.07 Mn |
API Access
Halozyme Therapeutics Cash from Financing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=HALO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-financing-activities", "ticker": "HALO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=HALO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();